Medication info
Jardiance 10 mg Tablet (Empagliflozin)

Jardiance 10 mg Tablet (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Light yellow, double-convex, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102270 · Approved 2021.03.12 · Insurance code 644915040

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
  • cardiovascular disease
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar levels in adults with type 2 diabetes. It may be used alone, but if blood sugar control is insufficient, it may be administered in combination with metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors. It is especially important to use this medication with caution in patients with type 2 diabetes who have cardiovascular disease, and to refer to the relevant clinical trial information. This drug is effective in improving blood sugar management and preventing complications in patients.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other antihyperglycemic agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dosage adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistently reduced glomerular filtration rate of < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dosage adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dosage adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4, General Precautions).

Precautions

This medication should not be used in certain patients. First, individuals allergic to the active ingredient or any component of this medication should avoid taking it. Additionally, it should not be administered to patients with type 1 diabetes or those experiencing diabetic ketoacidosis. Patients with severely impaired renal function, defined as a glomerular filtration rate of less than 30 mL/min/1.73m2 or those with end-stage renal disease or who are undergoing dialysis should also refrain from using this medication. This medication contains lactose, so it should not be given to patients with lactose intolerance or genetic lactose enzyme deficiency. Patients with mildly impaired renal function should use this medication with caution. Patients with a glomerular filtration rate of less than 60 mL/min/1.73m2 should not initiate treatment with this medication and those already receiving it may need dosage adjustment or discontinuation. In cases of end-stage renal disease or undergoing dialysis, this medication is not expected to be effective and should not be used. Regular monitoring of renal function prior to and during treatment is essential. Patients with heart failure classified as mild to moderate by the New York Heart Association (Class I-II) should use it cautiously, whereas it is not recommended for those classified as severe (Class III-IV). Additionally, when taken with insulin or sulfonylureas, which are insulin secretagogues, there is a risk of hypoglycemia, and dosage adjustments of those medications may be necessary. Adverse reactions that may occur while taking this medication include hypoglycemia, genital infections, urinary tract infections, increased urination, and reduced fluid volume. In particular, the risk of hypoglycemia may be heightened when taken concurrently with insulin or sulfonylureas, so caution is advised. Serious side effects reported include ketoacidosis, Fournier's gangrene (perineal necrotizing fasciitis), and acute pyelonephritis; if symptoms occur, it is important to consult a physician immediately. This medication may cause fluid volume loss, necessitating caution in elderly patients or those with hypotension or cardiovascular disease during administration. Pregnant women are advised to avoid taking this medication, and it should be discontinued immediately if pregnancy is confirmed. Nursing mothers are also advised to discontinue breastfeeding while using this medication. It should not be used in pediatric patients under 18 years of age, as safety and efficacy have not been established. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment should be sought in the event of overdose. Store this medication out of reach of children and do not transfer it to other containers for safety. Caution is advised when driving or operating machinery, especially when taken in conjunction with insulin or sulfonylureas due to the risk of hypoglycemia. Regular monitoring of renal function and observation of unusual symptoms during treatment is important, and if any unusual symptoms occur, medical consultation should be sought immediately.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanititis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • itching
  • rash
  • hives
Show 204 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • elevated serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ureteral stones
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • lower back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • traction retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tubal-ovarian abscess
  • vestibular neuritis
  • abdominal pain
  • tooth decay
  • erosive gastritis
  • abdominal discomfort
  • gastroesophageal reflux disease
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • bloating
  • gastric polyp
  • gingival swelling
  • passage of bloody stools
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • paronychia
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory loss
  • perceptual disturbances
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinson's disease
  • polyneuropathy
  • sensory impairment
  • drowsiness
  • CNS-origin vertigo
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • puncture site pain
  • weight gain
  • electrocardiogram abnormalities
  • decrease in hemoglobin
  • increase in hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • kidney mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • hyperphagia
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • circular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • eye discomfort
  • eye congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasal bleeding
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • Iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular disorders
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • insomnia
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • constipation
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes
  • diabetic retinopathy
  • dry eyes
  • dyspnea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored tightly sealed to prevent exposure to air and moisture. It is best kept at room temperature between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Light yellow, double-convex, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.